{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:07:43Z","timestamp":1791724063092,"version":"4.3.4"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Tigecycline (TIG) is approved for use for the treatment of complicated intra-abdominal infections, skin and skin structure infections, as well as pneumonia. Acquired resistance or reduced susceptibility to TIG has been observed in Gram-negative rods, has seldom been reported in Gram-positive organisms, and has not yet been reported in\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Enterococcus faecium<\/jats:named-content>\n            . Using the serial passage method,\n            <jats:italic>in vitro<\/jats:italic>\n            mutant AusTig and\n            <jats:italic>in vitro<\/jats:italic>\n            mutants HMtig1 and HMtig2 with decreased TIG susceptibility (MICs, 0.25 \u03bcg\/ml) were obtained from strains\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">E. faecium<\/jats:named-content>\n            Aus0004 and HM1070 (MICs, 0.03 \u03bcg\/ml), respectively. In addition, two vancomycin-resistant\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">E. faecium<\/jats:named-content>\n            clinical isolates (EF16 and EF22) with reduced susceptibility to TIG (MICs, 0.5 and 0.25 \u03bcg\/ml, respectively) were studied. Compared to the wild-type strains, the\n            <jats:italic>in vitro<\/jats:italic>\n            mutants also showed an increase in the MICs of other tetracyclines. An efflux mechanism did not seem to be involved in the reduced TIG susceptibility, since the presence of efflux pump inhibitors (reserpine or pantoprazole) did not affect the MICs of TIG. Whole-genome sequencing of AusTig was carried out, and genomic comparison with the Aus0004 genome was performed. Four modifications leading to an amino acid substitution were found. These mutations affected the\n            <jats:italic>rpsJ<\/jats:italic>\n            gene (\n            <jats:italic>efau004_00094<\/jats:italic>\n            , coding for the S10 protein of the 30S ribosomal subunit),\n            <jats:italic>efau004_01228<\/jats:italic>\n            (encoding a cation transporter),\n            <jats:italic>efau004_01636<\/jats:italic>\n            (coding for a hypothetical protein), and\n            <jats:italic>efau004_02455<\/jats:italic>\n            (encoding the\n            <jats:sc>l<\/jats:sc>\n            -lactate oxidase). The four other strains exhibiting reduced TIG susceptibility were screened for the candidate mutations. This analysis revealed that three of them showed an amino acid substitution in the same region of the RpsJ protein. In this study, we characterized for the first time genetic determinants linked to reduced TIG susceptibility in enterococci.\n          <\/jats:p>","DOI":"10.1128\/aac.04174-14","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T05:13:34Z","timestamp":1414473214000},"page":"239-244","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":64,"title":["Genomic Analysis of Reduced Susceptibility to Tigecycline in Enterococcus faecium"],"prefix":"10.1128","volume":"59","author":[{"given":"Vincent","family":"Cattoir","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Caen Basse-Normandie, EA4655 U2RM (\u00c9quipe Antibio-R\u00e9sistance), Caen, France"},{"name":"CHU de Caen, Service de Microbiologie, Caen, France"},{"name":"CNR de la R\u00e9sistance aux Antibiotiques, Laboratoire Associ\u00e9 Ent\u00e9rocoques, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Isnard","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Caen Basse-Normandie, EA4655 U2RM (\u00c9quipe Antibio-R\u00e9sistance), Caen, France"},{"name":"CHU de Caen, Service de Microbiologie, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Cosquer","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Caen Basse-Normandie, EA4655 U2RM (\u00c9quipe Antibio-R\u00e9sistance), Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arl\u00e8ne","family":"Odhiambo","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Caen Basse-Normandie, EA4655 U2RM (\u00c9quipe Antibio-R\u00e9sistance), Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Bucquet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Caen Basse-Normandie, EA4655 U2RM (\u00c9quipe Antibio-R\u00e9sistance), Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Gu\u00e9rin","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Caen Basse-Normandie, EA4655 U2RM (\u00c9quipe Antibio-R\u00e9sistance), Caen, France"},{"name":"CHU de Caen, Service de Microbiologie, Caen, France"},{"name":"CNR de la R\u00e9sistance aux Antibiotiques, Laboratoire Associ\u00e9 Ent\u00e9rocoques, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Giard","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Caen Basse-Normandie, EA4655 U2RM (\u00c9quipe Antibio-R\u00e9sistance), Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2761"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2008.00383.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2014.870886"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/431672"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1857"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh125"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm397"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2012.09.005"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00456-12"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.5.1865-1871.2005"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn065"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.04.014"},{"key":"e_1_3_2_14_2","volume-title":"Abstr","author":"Cattoir V","year":"2014","unstructured":"Cattoir V, Bucquet F, Giard J-C. 2014. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium, abstr. C-843. Abstr 54th Intersci Conf Antimicrob Agents Chemother. American Society for Microbiology, Washington, DC."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00259-12"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.11.2720"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004380050315"},{"key":"e_1_3_2_18_2","volume-title":"Performance standards for antimicrobial susceptibility testing; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2013","unstructured":"Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; approved standard, 23rd ed, M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"23"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)82095-6"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002834"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-2920.2010.02355.x"},{"key":"e_1_3_2_22_2","first-page":"327","volume-title":"Antibiogram","author":"Poyart C","year":"2010","unstructured":"Poyart C. 2010. Tetracyclines, p 327\u2013337. In Courvalin P, Leclercq R, Rice LB (ed), Antibiogram. ASM Press, Washington, DC."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2005.11.146"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.12.004"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2009.10.018"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.10.011"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.10.028"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.12.010"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01803-13"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.10.4327-4334.2005"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00267249"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.04174-14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.04174-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:55:37Z","timestamp":1645484137000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.04174-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1128\/AAC.04174-14"],"URL":"https:\/\/doi.org\/10.1128\/aac.04174-14","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"2014-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-10-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}